Associate Director, Field Business Lead

About The Role

We are looking for a Field Business Lead to take ownership of Alnylam’s commercial efforts in Canada, with a focus on driving performance for OXLUMO and GIVLAARI. In this highly visible role, you’ll act as Alnylam’s primary customer-facing representative in Canada and play a central part in shaping and executing our local commercial strategy.

Reporting to the Head of Sales, North America, this role combines sales leadership with cross-functional collaboration—partnering with Medical Affairs, Patient Services, Market Access, and Marketing. This is an excellent opportunity for someone with a strong foundation in the Canadian rare disease landscape who thrives in a dynamic, fast-paced environment.

What You’ll Do

• Lead and execute country-level commercial tactics to achieve sales goals
• Develop account plans and engage key healthcare providers to identify and support appropriate patients
• Build and maintain trusted partnerships with healthcare stakeholders across Canada
• Support access initiatives and collaborate with our Patient Services Partner (PSP) to guide the product journey
• Represent Alnylam at major congresses and educational events
• Work cross-functionally with regional and global colleagues to ensure Canada-specific insights inform broader strategy
• Lead contracted sales resources, with potential for future internal team leadership
• Monitor KPIs, ensure strategic investment alignment, and contribute to forecasting and market planning
• Operate in full compliance with company policies and Canadian regulations
  
  

What We’re Looking For

• Proven success in pharmaceutical sales and key account management; sales leadership experience preferred
• Strong experience in rare and ultra-rare disease markets in Canada
• Understanding of Canadian public and private reimbursement pathways, especially in rare disease
• Bachelor's degree in Life Sciences required; Business degree a plus
• Bilingualism (English/French) is an asset
• Strong analytical, planning, and cross-functional collaboration skills
• Self-starter with the ability to work independently and travel extensively across Canada
  
  

Why Join Us?

At Alnylam, you’ll be part of a purpose-driven company with a track record of innovation and a commitment to patient impact. You’ll work in a highly collaborative environment with the chance to shape how we serve the Canadian market.

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.